RCMNY
KERX

Rubric Capital Management (New York)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Rubric Capital Management (New York)’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-199,883
Closed -$680K – 70
2018
Q3 		$680K Buy
+199,883
New +$721K 0.07% 50

Rubric Capital Management (New York)'s KERX Position: Q4 2018 in Review

Rubric Capital Management (New York) sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 199,883 shares — an estimated $680K sold.

Rubric Capital Management (New York) first reported a position in KERX in Q3 2018 and held it in 1 quarter. The position peaked at $680K in Q3 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Rubric Capital Management (New York) reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 199,883 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $680K.
  • Rubric Capital Management (New York) first reported a position in Keryx Biopharmaceuticals Inc in Q3 2018 and held it in 1 quarter.
  • Rubric Capital Management (New York)'s Keryx Biopharmaceuticals Inc position peaked at $680K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2018, filed 13 Feb 2019.